Stevanato Group (NYSE:STVN) Receives “Equal Weight” Rating from Morgan Stanley

Morgan Stanley reiterated their equal weight rating on shares of Stevanato Group (NYSE:STVN) in a research note published on Monday morning, Benzinga reports. The brokerage currently has a $30.00 price target on the stock.

STVN has been the subject of several other reports. Stephens restated an overweight rating and issued a $38.00 target price on shares of Stevanato Group in a research report on Monday, March 25th. BNP Paribas initiated coverage on Stevanato Group in a research note on Monday. They issued an outperform rating on the stock. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of Moderate Buy and a consensus target price of €33.63 ($35.77).

Stevanato Group Stock Down 0.7 %

STVN opened at €26.54 ($28.23) on Monday. The business has a fifty day simple moving average of €30.39 and a 200 day simple moving average of €29.51. Stevanato Group has a 1 year low of €23.00 ($24.47) and a 1 year high of €36.30 ($38.62). The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.50.

Stevanato Group (NYSE:STVN) last issued its quarterly earnings results on Thursday, March 7th. The company reported €0.18 ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of €0.19 ($0.20) by (€0.01) (($0.01)). Stevanato Group had a net margin of 13.43% and a return on equity of 14.31%. The company had revenue of €320.60 million during the quarter, compared to the consensus estimate of €326.85 million. During the same quarter last year, the firm posted $0.19 earnings per share. The company’s quarterly revenue was up 9.8% on a year-over-year basis. Equities analysts anticipate that Stevanato Group will post 0.67 earnings per share for the current fiscal year.

Institutional Trading of Stevanato Group

Several hedge funds and other institutional investors have recently made changes to their positions in STVN. Natixis Advisors L.P. grew its holdings in Stevanato Group by 1.9% during the 4th quarter. Natixis Advisors L.P. now owns 23,858 shares of the company’s stock worth $651,000 after acquiring an additional 449 shares during the last quarter. Personal CFO Solutions LLC increased its holdings in Stevanato Group by 4.6% in the fourth quarter. Personal CFO Solutions LLC now owns 12,186 shares of the company’s stock valued at $333,000 after purchasing an additional 534 shares during the period. First Horizon Advisors Inc. lifted its holdings in Stevanato Group by 14.1% during the 4th quarter. First Horizon Advisors Inc. now owns 5,311 shares of the company’s stock worth $145,000 after buying an additional 657 shares during the period. Fifth Third Bancorp lifted its stake in shares of Stevanato Group by 70.1% in the third quarter. Fifth Third Bancorp now owns 2,473 shares of the company’s stock worth $73,000 after acquiring an additional 1,019 shares during the period. Finally, PNC Financial Services Group Inc. increased its position in shares of Stevanato Group by 54.2% during the fourth quarter. PNC Financial Services Group Inc. now owns 3,089 shares of the company’s stock worth $84,000 after buying an additional 1,086 shares during the period.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.